|
C15ORF23 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.599000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.418800E-01 |
| Normal-vs-Stage2 |
6.593800E-01 |
| Normal-vs-Stage3 |
5.666600E-01 |
| Normal-vs-Stage4 |
1.642100E-02 |
| Stage1-vs-Stage2 |
9.961600E-01 |
| Stage1-vs-Stage3 |
2.541600E-01 |
| Stage1-vs-Stage4 |
5.923500E-03 |
| Stage2-vs-Stage3 |
3.801000E-01 |
| Stage2-vs-Stage4 |
1.159820E-02 |
| Stage3-vs-Stage4 |
4.987600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.818800E-01 |
| Normal-vs-AfricanAmerican |
2.199800E-01 |
| Normal-vs-Asian |
1.990210E-01 |
| Caucasian-vs-AfricanAmerican |
5.589700E-02 |
| Caucasian-vs-Asian |
5.886000E-01 |
| AfricanAmerican-vs-Asian |
1.964000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.094000E-01 |
| Normal-vs-Female |
7.114000E-01 |
| Male-vs-Female |
6.044200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.959970E-01 |
| Normal-vs-Age(41-60Yrs) |
5.970800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.795000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.831400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.756800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.141800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.684500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.049000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.104400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.632410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.117200E-01 |
| Normal-vs-Grade 2 |
7.905800E-01 |
| Normal-vs-Grade 3 |
8.702600E-01 |
| Normal-vs-Grade 4 |
2.685900E-02 |
| Grade 1-vs-Grade 2 |
4.397600E-01 |
| Grade 1-vs-Grade 3 |
2.747400E-01 |
| Grade 1-vs-Grade 4 |
9.975900E-03 |
| Grade 2-vs-Grade 3 |
6.436800E-01 |
| Grade 2-vs-Grade 4 |
1.720440E-02 |
| Grade 3-vs-Grade 4 |
3.202000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.404800E-01 |
| Normal-vs-ccB subtype |
1.096990E-01 |
| ccA subtype-vs-ccB subtype |
1.208440E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.025400E-01 |
| Normal-vs-N1 |
2.426000E-02 |
| N0-vs-N1 |
3.499800E-02 |
|
|
